Grants

ACN Grants

While the ACN does not directly administer grant funding, its members report grant income that supports work related to the ACN.  ACN researchers have been very successful at securing grants to support nanomedicine projects - the total value in 2014 was AUD $6.36M, while the value in 2015 is approximately AUD $3.8M.

We would like to congratulate our directors, Justin Gooding and Maria Kavallaris, on their successful ARC Program Grant which will commence in 2016 and provide AUD $7M of funding through 2020.  The projected grant income for 2016 is AUD $4.2M.

 

Current grants held by ACN members and used to fund ACN related research.

 


 

ARC Linkage Grant (LP130101035)

2013 – 2016 || $ 495,000

The development of tuneable materials to allow the three-dimensional printing of cells
J.J. Gooding, T.P. Davis, J. Ribiero, M. Kavallaris

 


 

ARC Industrial Transformation Training Centres (IC130100021)
2013 – 2016 || $ 2,100,000

Training Centre for Advanced Technologies in Food Manufacture
J. Arcot, N. Lee, R. Wills, J.J. Gooding, G. Fleet, R. Amal, M. Stenzel, V. Chen, M. Lim, A. Shrestha, F. Trujillo, P. Spicer, S. Taylor, G. Wright, J. Golding, J. Sellahewa, R. Buckow, D. Frank, D. Zabaras, S. Vishnumohan, F. Curulli, D. Hertford, D. McPherson

 


 

ARC Linkage Grant (LP110200610)
2011 – 2015 || $ 774,000

In situ bioremediation solutions for Australia’s organochlorine contaminated aquifers
M.J. Manefield, J.J. Gooding, D. Lam

 


 

NHMRC Development Grant (APP1075628)
2014 – 2016 || $ 567,562

HbA1c biosensor
J.J. Gooding

 


 

NHMRC Project Grant (APP1024723)
2012 - 2014 || $ 439,925

A nanomedicine strategy for detecting and modulating protease activity in vivo
J.J. Gooding, Di Girolamo, Wakefield

 


 

NHMRC Established Career Fellowship Award (APP1058299)
2014 - 2018 || $ 601,420

Regulation and targeting of the cancer cytoskeleton
M. Kavallaris, L. Wordeman

 


 

NHMRC Project Grant (APP1057805)
2014 - 2016 || $ 617,562

Lamin B1, a new anti-cancer target
G. Lessene, N. Kershaw, M. Kavallaris

 


 

ARC Centre of Excellence (CE140100036)
2014 – 2020 || $ 4,067,000

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
T. Davis, F. Caruso, C. Porter,  J.J. Gooding, M. Kendall, N. Voelcker, A. Whittaker, N. Bunnett, M. Kendall, E. Crampin, R. Parton, M. Kavallaris, B. Boyd, M. Kearns, K. Thurecht, A. Johnston, P. Thordarson, T. Nann, S. Corrie, K. Dawson, C. Hawker, D. Haddleton, A. Cameron, M. Stevens, K. McLean, N. Abbott, D. Lee, I. Greguric, J. Lewis

 


 

ARC Discovery Grant (DP140103290)
2014 – 2016 || $ 343,000

Structural domains of beta-tubulin and their role in microtubule dynamics and transport
M. Kavallaris, L. Wordeman

 


 

ARC Linkage Grant (LP130100774)
2013 – 2016 || $ 306,000

Controlling Light-harvesting with Complex Perylene Arrays
P. Thordarson, J.M. Hodgkiss, A. Falber

 


 

ARC Discovery Grant (DP130101512)
2013 – 2015 || $ 330,000

How are self-assembled gels formed? From trial-and-error to rational molecular design
P. Thordarson

 


 

ARC Future Fellowship (FT120100101)
2012 – 2016 || $ 824,000

Moving Supramolecular Assembly of Functional Systems into Water
P. Thordarson

 


 

Cancer Institute NSW Early Career Fellowship (13/ECF/01 )
2014 – 2017 || $ 599,000

Dextran-catechin conjugation with SPIONs: a potential targeted therapy against gliobastoma multiforme
O. Vittorio

 


 

ARC Centre of Excellence (CE140100011)
2014 – 2020 || $ 2,800,000

ARC Centre of Excellence in Advanced Molecular Imaging
J. Whisstock, J. Rossjohn, W. Heath, H. Quiney, K. Nugent, D. Godfrey, B. Abbey, D. Fairlie, K. Gaus, A. Peele, J. Davey, H. Chapman

 


 

NHMRC Program Grant (APP1037320)
2013 – 2017 || $ 1,750,000

Program in Membrane Interface
R. Parton, A. Yap, K. Alexandrov, K. Gaus

 


 

ARC Future Fellowship (FT120100096)
2012 – 2016 || $ 692,068

Multimodal polymeric nanocarriers designed for the controlled and site specific delivery of nitric oxide
C. Boyer

 


 

ARC Discovery Grant (DP130100107)
2013 – 2015 || $ 360,000

Design of multimodal polymeric nanoparticles as targeted carriers for the co-delivery of therapeutic molecules
C. Boyer, T. Davis